NPR News: Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval

Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval
The Food and Drug Administration approved a muscular dystrophy drug despite deeply flawed evidence. Was the decision a dangerous precedent or flexible pragmatism reflecting patients' values?

Read more on NPR
Children's Health
September 24, 2016 at 07:47PM